| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |